In June 2022, Enanta filed a lawsuit against Pfizer in a US district court in Massachusetts, claiming that the big pharma ...

Enata Pharmaceuticals is suing Pfizer in a European Union court, alleging Pfizer's Paxlovid Covid-19 antiviral violates one of its patents. Enata said its patent, published Wednesday in the European ...

Enanta Pharmaceuticals (NASDAQ:ENTA) announced on Wednesday a lawsuit filed in the EU against Pfizer (NYSE:PFE) and some of ...

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating novel, small ...

2:20 Health Canada approves Paxlovid, Pfizer’s COVID-19 pill As Paxlovid has become more widely used, some patients have reported that COVID-19 symptoms recurred after completing treatment and ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Pfizer, which announced a $3.5 billion cost-cutting program earlier this month, slashed $9 billion off its 2023 sales forecast after agreeing to take back nearly 8 million Paxlovid treatment ...

Around 30,000 courses of Pfizer’s oral antiviral treatment Paxlovid arrived in Canada last week, with 11,000 of those distributed to Ontario, noted Dr. Andrew Morris, a professor of infectious ...

An antiviral drug being hailed for its potential role in the treatment of COVID-19 is now available in Ontario, but doctors warn it comes with significant challenges including low supply. Around ...

Canada has approved the first oral COVID-19 treatment that can be taken at home: an antiviral drug from Pfizer called Paxlovid. The approval comes as Canada grapples with an Omicron-fueled surge ...

Enata Pharmaceuticals is suing Pfizer in a European Union court, alleging Pfizer's Paxlovid Covid-19 antiviral violates one of its patents. Enata said its patent, published Wednesday in the European ...